Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aea7960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Jingsen Ji und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive Interventional Radiology, Second Affiliated Hospital, School of Biomedical Engineering, Guangzhou Medical University…. Hauptthemen laut MEDLINE: Lymph Nodes, Immune Tolerance, Multiple Sclerosis, Antigens. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Tolerogenic dendritic cell (tolDC) vaccines are a promising antigen-specific therapy for multiple sclerosis (MS), yet their efficacy is limited by poor homing to secondary lymphoid organs and rapid loss of the tolerogenic phenotype in native inflamed lymph nodes. Here, we developed a 3D-printed tolerogenic artificial lymph node (tol-aLN) that creates a protected immune niche for durable tolerance induction. tolDCs were loaded onto a porous gelatin methacrylate scaffold engineered for sustained C-C motif chemokine ligand 21 (CCL21) release, recruiting naïve CD4 + T cells and shielding tolDCs from an inflammatory lymph node. Geometric optimization of an orthogonal lattice scaffold enhanced spatially confined DC–T cell interactions, promoting robust and stable induction of regulatory T cells (T reg cells). In experimental autoimmune encephalomyelitis (EAE), tol-aLN implantation attenuated disease even at advanced stages by inducing antigen-specific Foxp3 + T reg cells that trafficked to the spleen, lymph nodes, and central nervous system (CNS). Conditional T reg cell depletion abolished therapeutic efficacy, indicating that T reg cells are necessary mediators of tol-aLN–induced protection. Long-term studies revealed sustained remission without impairing systemic immunity. In a myelin oligodendrocyte glycoprotein (amino acids 1 to 125) (MOG 1–125 )–induced EAE model, multivalent tol-aLN also efficiently suppressed inflammatory B cells and autoantibody production, reprogramming CNS B cells toward a regulatory state. Single-cell transcriptomics further revealed a global reduction in interferon-stimulated gene activity and restoration of homeostatic microglial phenotypes. Collectively, tol-aLN offers a scalable, antigen-specific platform for immune tolerance and CNS protection, with translational potential for MS and other autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Minimally Invasive Interventional Radiology, Second Affiliated Hospital, School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, China.
- State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
- Human Organ Physiopathology Emulation System, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- Nanomedicine Research Center, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou China.
- Guangzhou National Laboratory, Guangzhou, China.
ORCID-Profile: Jingsen Ji, Xinhuan Wang, Lu Liu, Jing Zhang, Jiaqing Wan, Gengyou Li, Yuying Yao, Xiaobao Cao, Ya Liu, Qi Gu, Xing-Jie Liang, Weisheng Guo
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Ji, J., Wang, X., Liu, L., Zhang, J., Wan, J., Li, G., Xie, G., Qi, J., Xuan, L., Yao, Y., Liao, F., Cao, X., Liu, Y., Gu, Q., Liang, X. J., & Guo, W. (2026). Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aea7960
Vancouver
Ji J, Wang X, Liu L, Zhang J, Wan J, Li G, et al. Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aea7960
BibTeX
@article{Ji2026,
author = {Ji, Jingsen and Wang, Xinhuan and Liu, Lu and Zhang, Jing and Wan, Jiaqing and Li, Gengyou and Xie, Guangting and Qi, Jingyu and Xuan, Leyan and Yao, Yuying and Liao, Fangling and Cao, Xiaobao and Liu, Ya and Gu, Qi and Liang, Xing-Jie and Guo, Weisheng},
title = {Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aea7960}
}
EUVIMED